Clinical trial Incyte-30006
Prospective Registry of Iclusig(r) (Ponatinib) used in Clinical Practice for the Treatment of Patients with Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Prospective observational study
|
| Phase | Trial phase 4 |
| Academic trial | Non |
| Sponsor | Incyte Corporate |
| BECT Identifier | B322201629750 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03678454 |
| Inclusion criteria | Under Iclusig regimen |
| Last update |